Alfonso Rodríguez‐Gil

1.2k citations
30 papers · 844 indexed · h-index 15

Alfonso Rodríguez‐Gil

28 papers receiving 839 citations

Peers

Alfonso Rodríguez‐Gil
Comparison fields: 5 of 79
  • Molecular Biology 509
  • Aging 11
  • Biomedical Engineering 192
  • Hematology 41
  • Pharmaceutical Science 20
Replace Román González‐Prieto with:
Román González‐Prieto Netherlands
Hidefumi Mukai Japan
Jerry Leung Canada
David S. Roberts United States
Gregor Kijanka Ireland
Jiayi Qian China
Yi-Ting Cheng United States
Meifu Feng China
Benjamin Demaree United States
Wies Deckers Belgium
Alfonso Rodríguez‐Gil relative to Román González‐Prieto Netherlands Román González‐Prieto's profile →
Citations per field
00.5×
Román González‐Prieto · 1×
Citations per year

Countries citing papers authored by Alfonso Rodríguez‐Gil

Since Specialization
Citations

This map shows the geographic impact of Alfonso Rodríguez‐Gil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alfonso Rodríguez‐Gil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alfonso Rodríguez‐Gil more than expected).

Fields of papers citing papers by Alfonso Rodríguez‐Gil

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alfonso Rodríguez‐Gil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alfonso Rodríguez‐Gil. The network helps show where Alfonso Rodríguez‐Gil may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Alfonso Rodríguez‐Gil, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Alfonso Rodríguez‐Gil Line = papers co-authored together Alfonso Rodríguez‐Gil links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20252
2 20250
3 20242
4 20240
5 20224
6 20226
7 20214
8 202053
9 20197
10 20197
11 201811
12 201723
13 201624
14 201616
15 201333
16 200979
17 200951
18 2006125
19 200647
20 2005162

About Alfonso Rodríguez‐Gil

Alfonso Rodríguez‐Gil is a scholar working on Hematology, Molecular Biology and Virology, having authored 30 papers that have together received 844 indexed citations. Recurring topics across this work include Genomics and Chromatin Dynamics (9 papers), RNA Research and Splicing (7 papers), RNA and protein synthesis mechanisms (6 papers), Hematopoietic Stem Cell Transplantation (5 papers), Innovative Microfluidic and Catalytic Techniques Innovation (4 papers), RNA modifications and cancer (4 papers), Electrohydrodynamics and Fluid Dynamics (3 papers) and Multiple Myeloma Research and Treatments (3 papers). The work is most often cited by research in Molecular Biology (509 citations), Aging (11 citations) and Biomedical Engineering (192 citations). Alfonso Rodríguez‐Gil has collaborated with scholars based in Spain, Germany and United States. Frequent co-authors include Sebastián Chávez, Lucía Martín‐Banderas, Alfonso M. Gañán‐Calvo, María Victoria Flores, Ángel Cebolla, Pascual Riesco Chueca, M. Lienhard Schmitz, Vicent Pelechano, José García‐Martínez and José E. Pérez‐Ortín.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026